Development of cryopreserved lung slices for research
Each individual responds differently to medicines or chemicals – a fact that has long posed challenges for the development of new therapies and safety assessments. With the COLDIMPACT project, three Fraunhofer Institutes (ITEM, IWS and IBMT) are laying the foundation for a decisive advance: the development of high-quality cryopreserved tissue slices with an almost unlimited shelf life. This makes it possible to use human tissue flexibly and on demand for research and development, independent of the availability of fresh material.
The goal is clear: disease models based on human tissue samples are intended to enable more reliable predictions of the efficacy and safety of new medicines – far beyond the current limitations of animal testing and the restricted availability of fresh tissue. COLDIMPACT thus addresses an urgent need in science and industry and lays the groundwork for innovative test systems that take patient-specific contexts into account and significantly improve access to relevant models.
Fraunhofer Institute for Toxicology and Experimental Medicine